Processa Pharmaceuticals, Inc PCSA 深 滬
等待開盤 10-09 09:30:00 美东时间
0.4789
+0.119
+33.03%
華盛通- 最 高0.5697
- 今 開0.56
- 成交量 1.21亿股
- 最 低 0.453
- 昨 收 0.36
- 總市值 2411.22万
- 52周最高 1.50
- 市盈率 靜 --
- 換手率 239.94%
- 52周最低 0.15
- 委 比 -49.62%
- 總股本 5034.91万
- 歷史最高 284.80
- 量 比 2.27
- 振 幅 32.42%
- 歷史最低 0.15
- 每 手 1
- 風險率 3.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Processa Pharmaceuticals shares are trading higher. The stock has recently gained social media buzz.
Processa Pharmaceuticals shares are trading higher. The stock has recently gain...
今天 00:56
Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?
Processa Pharmaceuticals shares jumped 37.5% after hours following a strong regular session, despite facing significant losses over the past year.
10-08 15:40
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market ...
10-07 17:28
Processa Pharmaceuticals Reschedules Special Shareholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has issued an announcement. On September 2...
09-10 22:59
Processa Pharmaceuticals Adjourns Special Shareholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has shared an announcement. On September 2...
09-03 05:27
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $2 to $1.
09-02 19:18
Processa Pharmaceuticals Relocates 2025 Stockholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has issued an announcement. On August 25, ...
08-26 05:48
Processa Pharma Q2 EPS $(0.25) Misses $(0.20) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.20) by 25 percent. This is a 75.25 percent increase over losses of $(1.01) per share from
08-08 05:54
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
Processa Pharmaceuticals secured strategic investments and is exploring blockchain-based assets as part of its financial strategy to diversify capital, enhance flexibility, and reduce dilution for shareholders. The company aims to leverage emerging financial technologies for long-term value creation while maintaining regulatory compliance. CEO George Ng highlighted the focus on innovative financial strategies to support shareholders and stakehold...
08-07 12:30
Processa Pharmaceuticals Reschedules Annual Shareholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has provided an announcement. On June 30, ...
07-16 00:57
